
The TSX Tech Surge Isn't About Innovation—It's a Quiet Canadian Reckoning
Forget the Nasdaq hype. The TSX technology rally signals a deep, structural shift in Canadian capital, not just a rebound.

Forget the Nasdaq hype. The TSX technology rally signals a deep, structural shift in Canadian capital, not just a rebound.

The EPA's latest move isn't just a policy shift; it’s a calculated sacrifice of public health for corporate profit. Unpacking the hidden costs of this rollback.

Beyond the headlines, public health reform is succumbing to 'enshittification.' We analyze who profits as service quality plummets.

The Africa CDC's Health Workforce Compact is hailed as a win, but we dissect the hidden costs and the real power shift in continental healthcare investment.

The buzzword 'learner-centered instruction' is sweeping universities, but beneath the veneer lies a dangerous shift in academic power and funding.

Director V Kamakoti's Padma Shri is being hailed, but the real story behind this IIT Madras achievement reveals systemic flaws in Indian science funding.

The 'guerrilla war on science' waged by political actors isn't just about abortion; it's a chilling blueprint for dismantling evidence-based medicine.

Forget policy debates. The targeted dismantling of medical science by political forces is a calculated strategy to control women's bodies.
The sudden rise of Australia's newest billionaire isn't about luck; it's about a tectonic shift in global **technology** investment. Unpacking the hidden winners.

North Carolina's AI leadership claim is built on student hype, but the real battle for **artificial intelligence** talent is about to expose deeper structural flaws.

The promised 'four paths forward for US scientists' are a smokescreen. The real crisis in **US science funding** is deeper, driven by political capture.

The call for "profound political change" in Venezuela isn't just about democracy; it's about resurrecting the ghost of its scientific past. The brain drain is terminal.